Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer
This study is ongoing, but not recruiting participants.
Study NCT00356681   Information provided by Amgen
First Received: July 24, 2006   Last Updated: November 5, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Neoplasms
Breast Tumors
Breast Cancer
Additional conditions recognized in this trial
Neoplasms
Recurrence
More general conditions related to this trial
Breast Diseases
Disease Attributes
Neoplasms by Site
Pathologic Processes
Skin Diseases
Interventions listed in this trial
AMG 706 placebo
Bevacizumab
AMG 706
Additional drug interventions recognized in this trial
Paclitaxel
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Growth Inhibitors
Growth Substances
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
Amgen


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services